Detalhe da pesquisa
1.
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.
Gut
; 73(4): 659-667, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879886
2.
Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide.
J Hepatol
; 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38901675
3.
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods.
Liver Int
; 44(3): 831-837, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247385
4.
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension.
J Hepatol
; 77(6): 1525-1531, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973578
5.
Circulating cell-free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients.
J Viral Hepat
; 28(3): 464-474, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33260272
6.
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs.
Hepatology
; 72(6): 1912-1923, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762045
7.
Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.
J Hepatol
; 72(1): 34-44, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31348999
8.
The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy.
Liver Int
; 40(8): 1987-1996, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301212
9.
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
J Hepatol
; 70(4): 615-625, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529504
10.
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
Gastroenterology
; 154(6): 1764-1777.e7, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378197
11.
TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals.
J Viral Hepat
; 26(10): 1233-1236, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31177595
12.
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy.
Liver Int
; 39(10): 1964-1974, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31323159
13.
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir.
Liver Int
; 39(3): 484-493, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30525275
14.
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
Liver Int
; 38(3): 417-423, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28732143
15.
Hepatitis delta virus and hepatocellular carcinoma: an update.
Epidemiol Infect
; 146(13): 1612-1618, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29991359
16.
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance.
J Hepatol
; 2017 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870666
17.
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
J Hepatol
; 66(5): 897-909, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28043874
18.
Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection.
Gut
; 65(12): 1998-2006, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26674359
19.
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
J Hepatol
; 63(5): 1118-25, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26100495
20.
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
Int J Cancer
; 135(5): 1247-56, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24510746